Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1996 1
1999 1
2000 1
2001 1
2004 1
2005 1
2007 1
2008 1
2011 1
2012 1
2013 2
2014 2
2015 9
2016 1
2017 2
2018 2
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality.
Pope CA 3rd, Turner MC, Burnett RT, Jerrett M, Gapstur SM, Diver WR, Krewski D, Brook RD. Pope CA 3rd, et al. Circ Res. 2015 Jan 2;116(1):108-15. doi: 10.1161/CIRCRESAHA.116.305060. Epub 2014 Oct 27. Circ Res. 2015. PMID: 25348167
RATIONALE: Growing evidence suggests that long-term exposure to fine particulate matter (PM2.5) air pollution contributes to risk of cardiovascular disease (CVD) morbidity and mortality. ...METHODS AND RESULTS: Data on 669 046 participants from the American Cancer S
RATIONALE: Growing evidence suggests that long-term exposure to fine particulate matter (PM2.5) air pollution contributes to risk of
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel disease.
Chapman TP, Frias Gomes C, Louis E, Colombel JF, Satsangi J. Chapman TP, et al. Aliment Pharmacol Ther. 2020 Jul;52(1):73-84. doi: 10.1111/apt.15771. Epub 2020 May 26. Aliment Pharmacol Ther. 2020. PMID: 32452591 Free article. Review.
This is important to address: 5-ASA therapy accounts for up to 25% of total healthcare costs in ulcerative colitis (UC), while almost a third of patients with Crohn's disease (CD) receive long-term 5-ASA despite no clear evidence of benefit. Further, rationalising medicati …
This is important to address: 5-ASA therapy accounts for up to 25% of total healthcare costs in ulcerative colitis (UC), while almost a thir …
Has the time come for metronomics in low-income and middle-income countries?
André N, Banavali S, Snihur Y, Pasquier E. André N, et al. Lancet Oncol. 2013 May;14(6):e239-48. doi: 10.1016/S1470-2045(13)70056-1. Lancet Oncol. 2013. PMID: 23639324 Review.
In 2008, 72% of cancer deaths occurred in low-income and middle-income countries, where, although there is a lower incidence of cancer than in high-income countries, survival rates are also low. ...Moreover, combined with drug repositioning, additional anticancer ef …
In 2008, 72% of cancer deaths occurred in low-income and middle-income countries, where, although there is a lower incidence of ca
Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy.
Bentley C, Peacock S, Abelson J, Burgess MM, Demers-Payette O, Longstaff H, Tripp L, Lavis JN, Wilson MG. Bentley C, et al. Health Res Policy Syst. 2019 Feb 7;17(1):17. doi: 10.1186/s12961-019-0411-8. Health Res Policy Syst. 2019. PMID: 30732616 Free PMC article.
We engaged Canadians through a series of deliberative public engagement events to determine their priorities for making cancer drug funding decisions fair and sustainable in Canada's publicly financed health system. ...CONCLUSIONS: The next steps for policy-makers s …
We engaged Canadians through a series of deliberative public engagement events to determine their priorities for making cancer drug f …
Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
Aitken SL, Tichy EM. Aitken SL, et al. Am J Health Syst Pharm. 2015 Feb 15;72(4):267-76. doi: 10.2146/ajhp140288. Am J Health Syst Pharm. 2015. PMID: 25631833 Review.
SUMMARY: RhIG is a human plasma derivative that targets red blood cells (RBCs) positive for Rh(O) antigen (also called D antigen). In the United States and other countries, the widespread use of RhIG has markedly reduced the occurrence of hemolytic disease of the fetus and …
SUMMARY: RhIG is a human plasma derivative that targets red blood cells (RBCs) positive for Rh(O) antigen (also called D antigen). In …
The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
Fintelmann FJ, Bernheim A, Digumarthy SR, Lennes IT, Kalra MK, Gilman MD, Sharma A, Flores EJ, Muse VV, Shepard JA. Fintelmann FJ, et al. Radiographics. 2015 Nov-Dec;35(7):1893-908. doi: 10.1148/rg.2015150079. Epub 2015 Oct 23. Radiographics. 2015. PMID: 26495797 Review.
On the basis of the National Lung Screening Trial data released in 2011, the U.S. Preventive Services Task Force made lung cancer screening (LCS) with low-dose computed tomography (CT) a public health recommendation in 2013. ...
On the basis of the National Lung Screening Trial data released in 2011, the U.S. Preventive Services Task Force made lung cancer
Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors.
Chinapaw MJ, Buffart LM, van Mechelen W, Schep G, Aaronson NK, van Harten WH, Stuiver MM, Kersten MJ, Nollet F, Kaspers GJ, van Dulmen-den Broeder E, Huisman J, Takken T, van Tulder M, Brug J. Chinapaw MJ, et al. Int J Behav Med. 2012 Jun;19(2):143-56. doi: 10.1007/s12529-011-9158-5. Int J Behav Med. 2012. PMID: 21556821 Free PMC article.
However, many previous studies had methodological weaknesses related to trial design, sample size, comparison group, outcome measures, short follow-up durations and programme content. PURPOSE: This paper aims to present the rationale and design of the clinical research sub …
However, many previous studies had methodological weaknesses related to trial design, sample size, comparison group, outcome measures, short …
Concocting that Magic Elixir: Successful Grant Application Writing in Dissemination and Implementation Research.
Brownson RC, Colditz GA, Dobbins M, Emmons KM, Kerner JF, Padek M, Proctor EK, Stange KC. Brownson RC, et al. Clin Transl Sci. 2015 Dec;8(6):710-6. doi: 10.1111/cts.12356. Epub 2015 Nov 18. Clin Transl Sci. 2015. PMID: 26577630 Free PMC article.
BACKGROUND: This paper reports core competencies for dissemination and implementation (D&I) grant application writing and provides tips for writing a successful proposal. ...RESULTS: The card sorting resulted in 12 core competencies for D&I grant application …
BACKGROUND: This paper reports core competencies for dissemination and implementation (D&I) grant application writing and provide …
Evaluation of Appropriate Mediastinal Staging among Endobronchial Ultrasound Bronchoscopists.
Miller RJ, Mudambi L, Vial MR, Hernandez M, Eapen GA. Miller RJ, et al. Ann Am Thorac Soc. 2017 Jul;14(7):1162-1168. doi: 10.1513/AnnalsATS.201606-487OC. Ann Am Thorac Soc. 2017. PMID: 28399376 Free PMC article.
RATIONALE: Endobronchial ultrasound (EBUS) has transformed mediastinal staging in lung cancer. ...OBJECTIVES: To assess the frequency with which pulmonologists, pulmonary fellows, and interventional pulmonologists endoscopically stage lung cancer appropriatel
RATIONALE: Endobronchial ultrasound (EBUS) has transformed mediastinal staging in lung cancer. ...OBJECTIVES: To assess the fr
Insurance billing and coding.
Napier RH, Bruelheide LS, Demann ET, Haug RH. Napier RH, et al. Dent Clin North Am. 2008 Jul;52(3):507-27, viii. doi: 10.1016/j.cden.2008.02.008. Dent Clin North Am. 2008. PMID: 18501731
The CPT and ICD.9.CM coding systems complement each other in that CPT codes provide the procedure and service information and ICD.9.CM codes provide the reason or rationale for a particular procedure or service. These codes are more commonly used for "medical necessity" de …
The CPT and ICD.9.CM coding systems complement each other in that CPT codes provide the procedure and service information and ICD.9.CM codes …
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page